首页 | 本学科首页   官方微博 | 高级检索  
检索        

参附针治疗慢性肺心病肺动脉高压症的临床研究
引用本文:叶焰,里自然.参附针治疗慢性肺心病肺动脉高压症的临床研究[J].辽宁中医杂志,2008,35(11):1676-1678.
作者姓名:叶焰  里自然
作者单位:[1]广州市中医医院呼吸内科,广东广州510130 [2]广州中医药大学2006级硕士研究生,广东广州510405
基金项目:广东省中医药管理局(103114)
摘    要:慢性肺心病肺动脉高压是临床多发病,而肺动脉高压是中老年慢性阻塞性肺病在血液动力学方面最多见和最严重的后果之一,也是慢性肺心病的诊断标准之一,其严重程度直接影响疾病的预后。而缺氧性肺血管收缩及小动脉机化是其主要病理变化。本研究旨通过中药制剂参附针与立其丁的临床疗效对比,探讨祖国医学温阳益气,散瘀逐饮原则对改善其病理变化的作用机理及临床疗效,从而减少发病率,提高患者生存率及生存质量,丰富中医治疗学。

关 键 词:慢性肺心病  肺动脉高压  参附针

Clinic Study on Shenfu Injection to Treat Pulmonary Arterial Hypertension of Chronic Cardiopulmonary Disease
YE Yan,LI Zi-ran.Clinic Study on Shenfu Injection to Treat Pulmonary Arterial Hypertension of Chronic Cardiopulmonary Disease[J].Liaoning Journal of Traditional Chinese Medicine,2008,35(11):1676-1678.
Authors:YE Yan  LI Zi-ran
Institution:YE Yan1,LI Zi-ran2 (1.Respiration Dept.of TCM Hospital of Guangzhou,Guangzhou 510130,Guangdong,China,2.Postgraduate of 2006,Guangzhou University of TCM,Guangzhou 510405,China)
Abstract:The Chronic Cardiopulmonary Disease,pulmonary hypertension(PAH) is frequently encountered illness in clinic,and PAH is one of the COPD patients' most common and severe consequences in hemadynamics.It is also one of the diagnostic codes of CCD,the severity direct influence the disease's prognosis.The main pathological changes of PAH are vasoconstriction and arteriole organization afterward.This research's purpose is approach the mechanism of action and clinical curative effect of TCM principles: warming yang...
Keywords:Chronic Cardiopulmonary Disease  Pulmonary Arterial Hypertension  Shenfu injection  
本文献已被 CNKI 维普 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号